Losartan potassium - Generic Drug Details

What are the generic sources for losartan potassium and what is the scope of patent protection?

Losartan potassium is the generic ingredient in two branded drugs marketed by Organon, Alembic Pharms Ltd, Apotex Corp, Aurobindo Pharma, Hetero Labs Ltd V, Hikma, Hisun Pharm Hangzhou, Ipca Labs Ltd, Jubilant Cadista, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, Mylan, Prinston Inc, Sandoz, Strides Pharma, Teva, Torrent Pharms, Unichem, Upsher Smith Labs, Watson Labs, and Zydus Pharms Usa Inc, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-eight drug master file entries for losartan potassium. Forty-seven suppliers are listed for this compound.

Summary for losartan potassium

US Patents:	0
Tradenames:	2
Applicants:	22
NDAs:	22
Drug Master File Entries:	38
Finished Product Suppliers / Packagers:	47
Raw Ingredient (Bulk) Api Vendors:	126
Clinical Trials:	80
Patent Applications:	6,497
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for losartan potassium
Drug Sales Revenues:	Drug sales revenues for losartan potassium
What excipients (inactive ingredients) are in losartan potassium?	losartan potassium excipients list
DailyMed Link:	losartan potassium at DailyMed

See drug prices for losartan potassium

See drug sales revenues for losartan potassium

Recent Clinical Trials for losartan potassium

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Hospital General de Niños Pedro de Elizalde	Phase 4
Armed Forces Post Graduate Medical Institute (AFPGMI), Rawalpindi	Early Phase 1
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	Phase 1/Phase 2

See all losartan potassium clinical trials

Pharmacology for losartan potassium

Drug Class	Angiotensin 2 Receptor Blocker
Mechanism of Action	Angiotensin 2 Receptor Antagonists

Medical Subject Heading (MeSH) Categories for losartan potassium

Angiotensin II Type 1 Receptor Blockers

Anti-Arrhythmia Agents

Antihypertensive Agents

Anatomical Therapeutic Chemical (ATC) Classes for losartan potassium

C09CA	Angiotensin II receptor blockers (ARBs), plain
C09C	ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C	Cardiovascular system

US Patents and Regulatory Information for losartan potassium

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apotex Corp	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	090790-003	Oct 6, 2010		DISCN	No	No
Hisun Pharm Hangzhou	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	204795-001	Apr 4, 2019		DISCN	No	No
Alembic Pharms Ltd	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	090428-003	Oct 6, 2010	AB	RX	No	No
Ipca Labs Ltd	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	200290-001	Aug 30, 2013	AB	RX	No	No
Teva	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	076958-001	Apr 6, 2010		DISCN	No	No
Lupin Ltd	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	078232-002	Oct 6, 2010	AB	RX	No	No
Hisun Pharm Hangzhou	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	204795-002	Apr 4, 2019		DISCN	No	No

Expired US Patents for losartan potassium

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-002	Apr 14, 1995
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-003	Oct 13, 1998
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-001	Apr 14, 1995
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-003	Oct 13, 1998
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-002	Apr 14, 1995
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-003	Oct 13, 1998
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-001	Apr 14, 1995